FCS

Medicus IT Announces COO, Sunita Arora, Appointed to Tech Alpharetta Board of Directors

Retrieved on: 
Tuesday, January 23, 2024
Student, ERP, Patient, Hospital, Artificial intelligence, Female, Software as a service, Medicus, STEAM, Alpharetta, Georgia, Innovation Center station, Sunita, FCS, Economic development, Innovation Academy Charter School, Management

ALPHARETTA, Ga., Jan. 23, 2024 /PRNewswire/ -- Medicus IT, a leading innovator in IT solutions for the healthcare industry, is thrilled to announce the appointment of Sunita Arora, Chief Operating Officer, to the Board of Directors of Tech Alpharetta, the nonprofit organization helping the City of Alpharetta lead tech innovation.

Key Points: 
  • ALPHARETTA, Ga., Jan. 23, 2024 /PRNewswire/ -- Medicus IT, a leading innovator in IT solutions for the healthcare industry, is thrilled to announce the appointment of Sunita Arora, Chief Operating Officer, to the Board of Directors of Tech Alpharetta, the nonprofit organization helping the City of Alpharetta lead tech innovation.
  • As Chief Operating Officer of Medicus IT, Sunita Arora oversees the strategic vision and day-to-day execution of service delivery and professional services.
  • We take immense pride in celebrating her role as a newly appointed board member of Tech Alpharetta.
  • The Board makes tech infrastructure recommendations to the City of Alpharetta, and helps guide Tech Alpharetta's mission of growing technology and innovation in Alpharetta.

Florida Cancer Specialists & Research Institute Appoints Joel Grossman, MD and Maen Hussein, MD to Executive Board

Retrieved on: 
Monday, January 15, 2024
Patient, Hematology, NCH Healthcare System, Lung cancer, Oncology, Committee on Finance, Environment, Division, FCS, Compensated emancipation, Publication, Physician

FORT MYERS, Fla., Jan. 15, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce the appointments of Joel Grossman, MD and Maen Hussein, MD to its Executive Board.

Key Points: 
  • FORT MYERS, Fla., Jan. 15, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce the appointments of Joel Grossman, MD and Maen Hussein, MD to its Executive Board.
  • FCS Chief Executive Officer Nathan H. Walcker added, "Our Executive Board members have a significant impact on the direction we take and the decisions we make in this highly dynamic and rapidly changing environment.
  • Dr. Hussein is the current President of the Florida Society of Clinical Oncology (FLASCO) board of directors.
  • "Their willingness to serve on the Executive Board is further evidence of their commitment to delivering world-class cancer care in community settings."

HYZON ACHIEVES 2023 VEHICLE DEPLOYMENT AND FUEL CELL DEVELOPMENT MILESTONES

Retrieved on: 
Tuesday, January 9, 2024
Hydrogen, Port, Drayage, SOP, Growth, Sale, FCS

ROCHESTER, N.Y., Jan. 9, 2024 /PRNewswire/ -- Hyzon Motors Inc. (NASDAQ: HYZN) (Hyzon or the company), a high-power hydrogen fuel cell technology manufacturer and global supplier of zero-emission heavy-duty fuel cell electric vehicles (FCEVs), today announced business updates reflecting achievement of critical 2023 commercial and operational milestones.

Key Points: 
  • Deployed 19 Hydrogen Fuel Cell Trucks Across Three Continents in 2023, Meeting Guidance of 15-20 Trucks
    Produced 25 200kW Fuel Cell B-Samples, Advancing Development to C-Sample Stage
    ROCHESTER, N.Y., Jan. 9, 2024 /PRNewswire/ -- Hyzon Motors Inc. (NASDAQ: HYZN) (Hyzon or the company), a high-power hydrogen fuel cell technology manufacturer and global supplier of zero-emission heavy-duty fuel cell electric vehicles (FCEVs), today announced business updates reflecting achievement of critical 2023 commercial and operational milestones.
  • "We deployed 19 FCEVs over three continents, including our first U.S. deliveries, and advanced our industry-leading, single-stack 200kW fuel cell technology from B- to C-sample development.
  • Paired with continued advancement of U.S. and international government investment in the hydrogen ecosystem, we expect significant achievements in 2024, including Start of Production (SOP) for our 200kW fuel cell system, delivering the first 200kW FCEVs into trial, and advancing our fuel cell vehicle product offering."
  • The standard industry approach to reach approximately 200kW of fuel cell power typically combines two 100kW fuel cell systems; Hyzon's single stack 200kW fuel cell system is 30% lower in weight and volume, and is estimated to be 25% lower in total fuel cell system cost compared to two of its 110kW fuel cell systems combined.

Florida's Largest, Long-Standing Community Oncology Practice Establishes Management Services Organization

Retrieved on: 
Friday, January 5, 2024
Patient, Ecosystem, MSO, Data collection, FCS, Physician, GPO, Nursing

FORT MYERS, Fla., Jan. 5, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) announces plans to re-examine its partnerships with distributors and suppliers in 2024, further strengthening scalability efforts driven by its newly established management services organization (MSO). The statewide community oncology practice, which conducted over 3.4 million patient visits in 2023, will actively seek agile partners capable of managing the dynamic challenges and increased market pressures accompanying the delivery of oncology care.

Key Points: 
  • The statewide community oncology practice, which conducted over 3.4 million patient visits in 2023, will actively seek agile partners capable of managing the dynamic challenges and increased market pressures accompanying the delivery of oncology care.
  • Florida Cancer Specialists & Research Institute establishes MSO; plans to seek new distributor and GPO partnerships.
  • Increasingly, over time, the oncology market has been encumbered with drug shortages and a record number of price increases.
  • The newly established MSO will enable FCS to remain a leader in the constantly evolving oncology environment through enhanced, value-based oncology care and reinforcing financial stability.

Florida Cancer Specialists & Research Institute Welcomes Gynecologic Oncologist Bradley Monk, MD, FACOG, FACS To Lead Late-Phase Clinical Research Program

Retrieved on: 
Wednesday, January 3, 2024
FACS, Cervical cancer, Research, Hope, MD, Health, Cancer, Standard of care, FACOG, FCS, Patient, Safety, Oncology nursing

FORT MYERS, Fla., Jan. 3, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that board-certified gynecologic oncologist Bradley Monk, MD, FACOG, FACS has joined the statewide practice. As medical director of the FCS Late-Phase Clinical Research Program, Dr. Monk will lead innovative initiatives to expand and deploy late-phase trials that are transforming cancer care worldwide. He is also providing care to patients at the FCS Palm Beach location, 1309 N. Flagler Drive, West Palm Beach, FL 33401.

Key Points: 
  • FORT MYERS, Fla., Jan. 3, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that board-certified gynecologic oncologist Bradley Monk, MD, FACOG, FACS has joined the statewide practice.
  • As medical director of the FCS Late-Phase Clinical Research Program, Dr. Monk will lead innovative initiatives to expand and deploy late-phase trials that are transforming cancer care worldwide.
  • "We are delighted to welcome Dr. Monk to our practice," said Lucio N. Gordan, MD , FCS President & Managing Physician.
  • Dr. Monk has extensive leadership experience in practice-changing clinical research and the development of clinical research programs in community oncology settings.

The Financial Communications Society (FCS) Announces Opening of the 30th Annual FCS Portfolio Awards

Retrieved on: 
Tuesday, January 2, 2024
Digital Marketing, Other Communications, Public Relations, Investor Relations, Media, Marketing, Content Marketing, Advertising, Communications, HSBC Bank, Intelligence, FCS, Prudential Financial, Creativity, Fintech, Morgan Stanley, Invesco, Financial adviser

The Financial Communications Society (FCS) proudly announces the opening of the prestigious FCS Portfolio Awards, marking its monumental 30th year in celebrating creative excellence in financial marketing, communications and media.

Key Points: 
  • The Financial Communications Society (FCS) proudly announces the opening of the prestigious FCS Portfolio Awards, marking its monumental 30th year in celebrating creative excellence in financial marketing, communications and media.
  • Starting January 2, 2024, financial services and fintech marketing professionals are welcome to submit their best work from 2023.
  • For three decades, the FCS Portfolio Awards have recognized the most creative, strategic, and impactful campaigns across financial sectors.
  • "We are thrilled to commemorate 30 years of the FCS Portfolio Awards," said Kevin Windorf, CEO of FCS.

Honda, Tokuyama, and Mitsubishi Corporation to Conduct Joint Demonstration of Decarbonizing Data Center Using By-product Hydrogen and Stationary Fuel Cell Power Station designed to Reuse Fuel Cell Systems from FCEVs

Retrieved on: 
Monday, December 25, 2023
Economics, FCS, Knowledge, Mitsubishi Corporation, Demonstration, Face, Tokuyama Corporation, FC

TOKYO, Dec 25, 2023 - (JCN Newswire) - Honda Motor Co., Ltd. (Honda), Tokuyama Corporation (Tokuyama), and Mitsubishi Corporation (MC) ("Project Members") will conduct a joint demonstration to operate a data center using by-product hydrogen and a stationary fuel cell (FC) power station designed to reuse FC systems from fuel cell electric vehicles (FCEVs).

Key Points: 
  • TOKYO, Dec 25, 2023 - (JCN Newswire) - Honda Motor Co., Ltd. (Honda), Tokuyama Corporation (Tokuyama), and Mitsubishi Corporation (MC) ("Project Members") will conduct a joint demonstration to operate a data center using by-product hydrogen and a stationary fuel cell (FC) power station designed to reuse FC systems from fuel cell electric vehicles (FCEVs).
  • ("Demonstration Project").
  • Project Members will explore the potential of reusing automotive FC systems in a stationary application.
  • The objective of the Demonstration Project is to reduce the economic burden on customers installing and operating stationary FC systems, which will contribute to the decarbonization of the electric power.

Carrum Health and Florida Cancer Specialists & Research Institute Partner on Breast Cancer Treatment Model

Retrieved on: 
Friday, December 22, 2023
Partnership, Cancer, Carrum, Victoria, Center of excellence, FCS, Patient, Radiation, Health insurance

FORT MYERS, Fla., Dec. 22, 2023 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) announced today a new partnership with Carrum Health, a value-based Centers of Excellence healthcare solution changing how cancer and surgical care are paid for and delivered, to provide high-quality, cost-effective breast cancer care to patients at FCS. Through employers, Carrum Health will offer patients a bundled package for breast cancer care that includes two years of coverage for treatment, which may comprise chemotherapy, radiation, and symptom management from FCS.     

Key Points: 
  • Through employers, Carrum Health will offer patients a bundled package for breast cancer care that includes two years of coverage for treatment, which may comprise chemotherapy, radiation, and symptom management from FCS.
  • The partnership will focus on patients with non-metastatic breast cancer in Florida.
  • In return, employers who have aligned with Carrum Health will benefit from the advanced oncology treatment options offered at the nearly 100 FCS locations across Florida.
  • FCS and Carrum plan to expand this collaboration to other cancers over time, enabling access for more Floridians to benefit from high-value cancer care.

Targeted Oncology™ announces recipients of its Oncology Icons award program

Retrieved on: 
Wednesday, November 15, 2023
Research, FACP, State university system, Royal college, University College Hospital, FCS, Hematology, Therapy, Urology, Internal medicine, Patient, Multimedia, Science, Gynaecology, Brooklyn Hospital Center, State, University of Ibadan, University, Survival, University College Hospital, Ibadan, Cornwall Regional Hospital, Brown, Quality of life, Committee on Finance, Nursing

CRANBURY, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Targeted Oncology™, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, is thrilled to announce the distinguished recipients of the prestigious Oncology Icons award program.

Key Points: 
  • CRANBURY, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Targeted Oncology™, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, is thrilled to announce the distinguished recipients of the prestigious Oncology Icons award program.
  • This program recognizes individuals who have made exceptional contributions to the field of oncology through their expertise, dedication and innovation.
  • “We are honored to acknowledge the outstanding contributions of these Oncology Icons,” said Erik Lohrmann, senior vice president of, oncology and urology.
  • Submissions for the Oncology Icons award program are accepted on a rolling basis throughout the year.

Florida Cancer Specialists & Research Institute Contributing to Cutting-Edge Advancements in Hematology Science

Retrieved on: 
Wednesday, December 13, 2023
Annual Reviews (publisher), ASH, BTK, Research, Bortezomib, Omicron, Conference, Bangladesh Technical Education Board, Poster, Mantle cell lymphoma, SLL, Risk, Science, Abstract, Drug development, Tyrosine kinase, Society, B-cell lymphoma, FACP, Rituximab, Reversibility, Delta, Phase, Nivolumab, Hospital, Safety, DRD, MCL, FCS, FDA, Lymphocytosis, Pivotal trial, Chronic lymphocytic leukemia, Meta-analysis, Artery, Bias, Coronary thrombosis, NHL, CLL, Pharmaceutical industry, Dietary supplement, Vaccine, Birth control, Incidence, Patient, Dexamethasone, Lenalidomide, Hematology, Relapse, Dacarbazine, MD, Doxorubicin

FORT MYERS, Fla., Dec. 13, 2023 /PRNewswire/ -- Research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) was presented in the cutting-edge advancements being shared at the American Society of Hematology (ASH) 65th Annual Meeting and Exposition in San Diego on Dec. 9 - 12, 2023. Scientific abstracts submitted by FCS hematologists and medical oncologists were among the 7,000 accepted submissions selected through an extensive peer review process.

Key Points: 
  • FORT MYERS, Fla., Dec. 13, 2023 /PRNewswire/ -- Research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) was presented in the cutting-edge advancements being shared at the American Society of Hematology (ASH) 65th Annual Meeting and Exposition in San Diego on Dec. 9 - 12, 2023.
  • Scientific abstracts submitted by FCS hematologists and medical oncologists were among the 7,000 accepted submissions selected through an extensive peer review process.
  • Pirtobrutinib has also been approved for patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
  • Once again, FCS is proud to have a strong presence, sharing the latest and most promising research and science that is moving the field forward."